Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c
Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.